In fiscal year 2023 — Oct. 1–Sept. 30, 2023 — 91°µÍø was awarded more than $8 million in technology maturation funding through the Department of Energy’s Technology Commercialization Fund, or TCF.
The Department of Energy’s 91°µÍø is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.